Sale to
March 2019
Anju Software, a clinical, medical affairs and commercial software and data platform for the life sciences industry, has received a majority investment from ABRY Partners.
- The transaction provides growth and acquisition capital for continued product enhancement and global expansion
- ABRY Partners has deep industry expertise across multiple technology subsectors, including healthcare IT, SaaS and information services
Anju Software
Anju Software is a leading provider of comprehensive software solutions to the life sciences industry. Anju provides an integrated platform spanning clinical, medical affairs and commercial operations. Anju solutions are used by large and small pharmaceutical companies, clinical research organizations (CRO), full service agencies and medical device companies. Data flow between functional areas, seamless communication with third party systems and AI-based data mining solutions to provide customers critical information throughout their ecosystem.
About ABRY Partners
Since its founding in 1989, ABRY has focused on media, communications, business and information services to become one of the most experienced private equity firms investing in North America and Europe. ABRY’s funds are deployed by our close-knit and diverse team of professionals, most of whom have built their careers at the firm.
Client Highlights
- 9 Transactions
- 6 Years of Partnership
Transaction Details
-
SectorsHealthcare & Life Sciences Technologies
-
ServiceM&A
-
OwnershipInvestor-Backed
-
Practices
Healthcare & Life Sciences
Sponsor Coverage
“Anju has delivered outstanding results for its customers and shareholders. We are joining hands with Abry to commence a new phase for the leadership team to accelerate innovation and further expedite growth. Our mantra for success is achieving optimal customer satisfaction combined with cutting edge, yet flexible products. We share the same vision with Abry and are very excited about this new partnership. ”